Off-The-Shelf Cancer Vaccine Elicits Strong Immune Response in Patients With Pancreatic and Colorectal Cancer
August 13, 2025
August 13, 2025
LOS ANGELES, California, Aug. 13 (TNSjou) -- The UCLA Health issued the following news release:
* * *
Off-the-shelf cancer vaccine elicits strong immune response in patients with pancreatic and colorectal cancer
Final trial results show durable T-cell responses and reduced relapse in patients with pancreatic and colorectal cancer
*
A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driv . . .
* * *
Off-the-shelf cancer vaccine elicits strong immune response in patients with pancreatic and colorectal cancer
Final trial results show durable T-cell responses and reduced relapse in patients with pancreatic and colorectal cancer
*
A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driv . . .